Table 2. Unstandardized coefficients derived from multiple regression models studying the association between RBM plasma analytes and SPARE AD adjusted for clinical diagnosis, age, and APOE ε4 presence.
Age | Clinical diagnostic group | APOE | Studied RBM analyte | ||
MCI | AD | ||||
CgA | 0.039 (p<0.001) | 1.92 (p<0.001) | 2.61 (p<0.001) | 0.29 (p = 0.0002) | −0.23 (p = 0.0020) |
Cortisol | 0.034 (p<0.001) | 1.96 (p<0.001) | 2.62 (p<0.001) | 0.29 (p = 0.0003) | 0.81 (p = 0.0048) |
IGFBP-2 | 0.031 (p<0.001) | 1.87 (p<0.001) | 2.61 (p<0.001) | 0.30 (p = 0.0001) | 0.59 (p = 0.0016) |
MIP1α | 0.033 (p<0.001) | 1.90 (p<0.001) | 2.61 (p<0.001) | 0.30 (p = 0.0001) | 0.61 (p = 0.13) |